XML 85 R74.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting - Summary of Significant Expenses and Other Segment Items (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting [Abstract]    
Revenues $ 71,323 $ 49,087
Direct costs and expenses (less employee related expenses and depreciation and amortization) 11,476 9,200
Employee related expenses 55,606 45,936
Contracted services expenses 6,616 5,261
Sales and marketing education and event expenses 7,574 7,195
Occupancy and equipment service expenses 4,055 5,372
Clinical trials and associated costs 1,180 1,663
Depreciation and amortization expense 5,773 3,328
Share-based compensation expenses 6,638 5,373
Interest expense 8,258 9,536
Other segment items 7,078 8,369
Net loss $ (42,931) $ (52,146)